The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer D Campa, M Gentiluomo, A Stein, MN Aoki, M Oliverius, L Vodičková, ... Critical Reviews in Oncology/Hematology 186, 104020, 2023 | 22 | 2023 |
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma C Corradi, G Lencioni, M Gentiluomo, A Felici, A Latiano, G Kiudelis, ... Journal of Medical Genetics 60 (10), 980-986, 2023 | 14 | 2023 |
Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma G Peduzzi, A Felici, R Pellungrini, F Giorgolo, R Farinella, M Gentiluomo, ... Digestive and Liver Disease 56 (6), 1054-1063, 2024 | 10 | 2024 |
The local environment and germline genetic variation predict cancer risk in the UK Biobank prospective cohort A Felici, G Peduzzi, F Giorgolo, A Spinelli, M Calderisi, A Monreale, ... Environmental Research 241, 117562, 2024 | 9 | 2024 |
Explainable machine learning identifies a polygenic risk score as a key predictor of pancreatic cancer risk in the UK Biobank G Peduzzi, A Felici, R Pellungrini, D Campa Digestive and Liver Disease, 2024 | 2 | 2024 |
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk C Corradi, G Lencioni, A Felici, C Rizzato, M Gentiluomo, S Ermini, ... International journal of cancer 155 (8), 1432-1442, 2024 | 2 | 2024 |
Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review D Campa, A Felici, C Corradi, G Peduzzi, M Gentiluomo, R Farinella, ... Mutagenesis, gead034, 2023 | 2 | 2023 |
Biomarkers, Omics and Artificial Intelligence for Early Detection of Pancreatic Cancer. K Murray, L Oldfield, I Stefanova, M Gentiluomo, P Aretini, R O’Sullivan, ... Seminars in Cancer Biology, 2025 | | 2025 |
Author's Reply: Comment on “Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma” G Peduzzi, A Felici, R Pellungrini, R Farinella, D Campa, F Giorgolo, ... Digestive and Liver Disease, 2025 | | 2025 |
Hormonal influence on pancreatic ductal adenocarcinoma: deciphering gender disparities in risk assessment G Peduzzi, A Felici, L Archibugi, G Capurso, D Campa Pancreatology 24, e113, 2024 | | 2024 |
Exposome and genome interactions and pancreatic ductal adenocarcinoma susceptibility in the UK Biobank G Peduzzi, A Felici, R Pellungrini, M Gentiluomo, M Calderisi, A Monreale, ... Pancreatology 23, e28, 2023 | | 2023 |
The PSCA-rs2976395 functional variant is associated with pancreatic cancer development C Corradi, G Lencioni, A Felici, C Rizzato, M Gentiluomo, S Ermini, ... Pancreatology 23 (Suppl 1), 133-134, 2023 | | 2023 |